# Production of Synthetic Adjuvant System (SAS)

> **NIH NIH N44** · INIMMUNE CORPORATION · 2020 · $1,992,471

## Abstract

The company will develop a synthetic adjuvant system (SAS) containing a TLR-4 agonist combined with a saponin-based adjuvant, in which both components synergize to elicit a Th1-biased immune response.

## Key facts

- **NIH application ID:** 10244740
- **Project number:** 75N93020C00021-0-9999-1
- **Recipient organization:** INIMMUNE CORPORATION
- **Principal Investigator:** SHANNON MILLER
- **Activity code:** N44 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $1,992,471
- **Award type:** —
- **Project period:** 2020-06-01 → 2022-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10244740

## Citation

> US National Institutes of Health, RePORTER application 10244740, Production of Synthetic Adjuvant System (SAS) (75N93020C00021-0-9999-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10244740. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*